REGENXBIO Inc (RGNX): Wutah pendapatan kuartal marang kuartal

Logo korporat perusahaan regenxbio.com (RGNX)

The development of REGENXBIO Inc. (RGNX) relies on gene drug test results and external financing. Quarterly revenue growth rates visualize current income dynamics, where the -69.20 level captures the latest values. Despite global logistics risks and patent disputes, a strong reputation in bioengineering and partnerships with pharma behemoths strengthen the company's investment potential.

RGNX (REGENXBIO Corp) riwayat Wutah dodolan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan REGENXBIO (RGNX)

- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
- indikator dhuwit lan ilining kas:
Analisis komprehensif perusahaan:RGNX - REGENXBIO
Produk seri regenxbio.com

Fundamental asset selection requires analyzing revenue dynamics to identify market cycles. This metric measures the rate of revenue change between quarters, signaling a cooling of demand prior to the publication of official reports. For REGENXBIO Inc. (RGNX), this growth confirms the effectiveness of investments in an elite staff of geneticists and the R&D base. By analyzing the quarterly sales growth rate, an investor assesses the commercialization of the company's gene platforms.

Pesaing langsung

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|RNA (Avidity Corp) - Wutah pendapatan triwulanan|CRISPR Therapeutics Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal genedx.com (WGS)|Wutah pendapatan triwulanan ultragenyx.com (RARE)|Wutah pendapatan triwulanan BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Tingkat wutah pendapatan sajrone kuartal|twistbioscience.com - Wutah pendapatan triwulanan|10x Genomics, Inc. - Owah-owahan dodolan kuartal marang kuartal|NTLA (Intellia Corp) - Wutah dodolan triwulanan|Wutah dodolan triwulanan stoketherapeutics.com|Wutah dodolan triwulanan BLFS|Wutah dodolan triwulanan Wave Life Sciences Corp (WVE)|Wutah pendapatan triwulanan MAZE|Tingkat wutah dodolan sajrone kuartal Sionna Therapeutics Inc|Wutah pendapatan kuartal marang kuartal Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Tingkat wutah pendapatan sajrone kuartal|QURE - Wutah pendapatan kuartal marang kuartal|MeiraGTx Holdings (MGTX) - Wutah dodolan triwulanan|SLDB (Solid Corp) - Wutah dodolan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Ocugen Corp OCGN|PACB (Pacific Biosciences) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BNTC|Wutah pendapatan triwulanan DSGN|Wutah dodolan triwulanan Rocket Pharma RCKT|Tingkat wutah dodolan sajrone kuartal FDMT|Wutah pendapatan triwulanan Lexeo Therapeutics LXEO|KRRO - Wutah pendapatan kuartal marang kuartal|EDIT (Editas Medicine, Inc.) - Wutah dodolan kuartal marang kuartal|SLN: Wutah pendapatan triwulanan|ProQR - Tambahing pendapatan triwulanan|CDXS (Codexis) - Wutah pendapatan triwulanan|Sangamo (SGMO) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)